Alnylam Pharmaceuticals, Inc. Liquidation Value
ALNY
Other
Cash & Equivalents
$1.66B
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $1.66B
Total Obligations: -$1.74B
$-79.70M
Per share: $-0.60
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $1.66B
AR: $777.57M
Total Obligations: -$1.74B
$697.86M
Per share: $5.27
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $1.66B
AR: $777.57M
Inventory: $82.72M
Total Obligations: -$1.74B
$780.58M
Per share: $5.90
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-79.70M | $-0.60 |
| Liquid Liquidation Value | $697.86M | $5.27 |
| Operating Liquidation Value | $780.58M | $5.90 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $1.66B |
| Accounts Receivable | $777.57M |
| Inventory | $82.72M |
| Current Liabilities | $1.47B |
| Long-term Debt | N/A |
| Op. Lease Liability | $270.61M |
| Finance Lease | N/A |
| Shares Outstanding | 132.4M |
Explore all 181 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.66B | $777.57M | $82.72M | $115.72M | $1.47B | N/A | $270.61M | N/A |
| 2025-09-30 | $1.49B | $964.77M | $75.38M | $117.59M | $1.56B | N/A | $268.18M | N/A |
| 2025-06-30 | $1.11B | $567.11M | $71.69M | $102.39M | $1.30B | N/A | $270.54M | N/A |
▼ Community Notes